Abstract
For many years, heart transplantation has been an established procedure for patients with end-stage heart failure using the so-called “Standard Criteria” for an optimal heart donor. However, annually listed patients for heart transplantation greatly increased worldwide, and the use of extended criteria donor hearts has been utilized as many as possible in many countries. In this chapter, firstly, pathophysiology of brain death is explained. Secondly, donor assessment and issues of extended criteria donors are introduced. Then, donor management to maximize the heart graft availability, and the Japanese donor assessment and evaluation system and its outcome are reviewed.
Reference28 articles.
1. Fukushima N. Revised organ transplant act and transplant surgeons. Japan Medical Association Journal. 2011;54(6):387-391
2. Fukushima N, Ono M, Nakatani T, et al. Strategies for maximizing heart and lung transplantation opportunities in Japan. Transplantation Proceedings. 2009;41(1):273-276
3. Novitzky D, Cooper DK, Rosendale JD, Kauffman HM. Hormonal therapy of the brain-dead organ donor: Experimental and clinical studies. Transplantation. 2006;82(11):1396-1401
4. Mascia L, Mastromauro I, Viverti S, et al. Management of optimize organ procurement in brain dead donors. Minerva Anesthesiol. 2009;75:125-133
5. Kaul DR, Vece G, Blumberg E, et al. Ten years of donor-derived disease: A report of the disease transmission advisory committee. American Journal of Transplantation. 2021;21:689-702. DOI: 10.1111/ajt.16178